CN Bio secures a £180k Innovate UK grant to develop organ-on-a-chip system for drug behaviour predictions

CN Bio provides organ-on-a-chip systems that recreate key aspects of human tissue biology in the laboratory. Its PhysioMimix microphysiological systems give drug discovery and development teams decision-ready data on drug safety, efficacy and pharmacokinetics without relying on animal studies.